Executive Summary

• Ivermectin is only approved as an anti-parasitical, and due to financial incentives, that is all the FDA will ever approve for it.

Introduction

In a previous article titled How Ivermectin Is Useful for Treating Cancer we covered the evidence for the benefits of Ivermectin for cancer. But cancer patients should never expect Ivermectin to be approved by the FDA, and this article explains why.

Our References for This Article

If you want to see our references for this article and related Brightwork articles, visit this link.

Why the FDA Will Never Approve Ivermectin for Other Uses

The FDA cannot approve ivermectin for other uses because it is a generic, so no drug company will pay to perform the clinical trial and submit it to the FDA. So it’s no that Ivermectin has not been shown to have considerable benefits against multiple diseases, including improving the immune system and reducing inflammation; it’s that no drug company can make money by pushing it through the FDA as it has come off of patent. Anyone who disagrees with this should answer this question.

Critical Question

“What generic drug has ever been pushed by a pharma company through the FDA?”

The Reality of How the FDA Functions

The answer is that only drugs that can be patented are pushed through the FDA. Therefore, saying a drug “has not been approved for use against XYZ” when it was approved 40 years ago and is no longer on a patent is misleading the reader, as only patentable drugs are approved.

Now the FDA and NIH Keep Effective Generics From Being Repurposed

The FDA and NIH could fund studies and then approve Ivermectin for other uses, but the FDA and NIH don’t report to the public. They report to pharmaceutical companies and belong much more to the pharmaceutical companies as institutions than the US government.

These are the number of studies into Ivermectin currently being funded by the NIH. Zero. This is precisely the number of studies the pharmaceutical companies told the NIH to fund. 

Under the current drug approval system, who will if the government does not fund a submission to the FDA? Also, the FDA does not approve drugs unless they are submitted by the “in the club,” which is pharmaceutical companies. The system is only designed to get patented drugs approved.

Misleading Readers About How the Patent Drug System and FDA Approval System Works

As should be clear, the presentation by the establishment media leaves out everything written above. They make it appear that if Ivermectin were proven effective against whatever disease or ailment, it would have been approved already. However, they leave out this is not how the patent drug system works. And this is not only limited to the topic of Ivermectin. There is no mechanism for any generic drug to be repurposed and given approval for other diseases. However, pharmaceutical companies are constantly getting on patent drugs repurposed. Which drugs are approved is based upon which drugs are profit-maximizing for pharmaceutical companies.

The Lack of Public Service Function of the FDA

The FDA does not have any public service function where they fund clinical trials into generic medications. They rely 100% on pharmaceutical companies to set the agenda of what drugs they will look at.

The pharmaceutical companies are their previous and future employers for the top people at the FDA. With the FDA, the pharmaceutical companies get a faux public service entity that ostensibly reports to the government but, in reality, reports to them. The FDA will rubber-stamp virtually any drug submitted to them.

Plenty of Ivermectin Studies that the FDA and MDs Don’t Discuss

There are many studies on Ivermectin for several different uses that pharmaceutical companies do not fund, and the FDA will not look at them. The most well-known are the studies published at C19Early.com, which show the benefits of Ivermectin against covid.

The more studies a treatment has, the more it declines in effectiveness. Therefore the top-scoring treatments in this list, Iota-Carragee, and Proxalutamide, with only 1 study and four studies, don’t count. However, Ivermectin has 87 studies and a 63% improvement. Look at all of the treatments with larger numbers of studies.

• Exercise
• Colchicine
• Vitamine D

During the pandemic, which of these was promoted by health authorities?

The answer is none of them. They deny studies into these items even exist. I have been curious to observe false statements about the non-existence of studies that I have read by the establishment media and the pharmaceutical company MDs they bring on.

The lockdown and restrictions on outdoor activities and closed gyms reduced the frequency of exercise, reducing the strength of the population’s immune system.

Pharma’s Diminishment of Generic Drugs

Colchicine, like Ivermectin, is generic.

Merck created a generic substitute for Ivermectin because they need to sell patent drugs. The video above shows how Molnupiravir is far less safe and less effective than Ivermectin, but it meets Merck’s primary optimization objective, it maximizes Merck’s profits. But Merck must diminish Ivermectin to make way for Molnupiravir, and that is what they have been doing. 

Pharma companies can’t make money on Ivermectin, Colchicine, Vitamin D, or exercise, and because of this, their PR front end, which is the FDA/NIH/CDC never discussed these essential treatments.